Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro

takehiro kawashiri, Anna Miyagi, Shiori Shimizu, Nao Shigematsu, Daisuke Kobayashi, Takao Shimazoe

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Chemotherapy agents such as oxaliplatin, cisplatin, paclitaxel, and bortezomib frequently cause severe peripheral neuropathy and there is currently no effective strategy to prevent this. Dimethyl fumarate (DMF) is a new oral drug for the treatment of multiple sclerosis, and has neuroprotective effects via up-regulation of the nuclear factor-erythroid-2-related factor 2 (Nrf2)-dependent antioxidant response. In this study, we investigated the effect of DMF on chemotherapy agent-induced neurodegenerations in cultured cells. We found that DMF and its metabolite monomethyl fumarate (MMF) attenuated oxaliplatin-, cisplatin-, and bortezomib- (but not paclitaxel-) induced inhibition of neurite outgrowth, but had no effect on cell death as a result of these agents in cultured PC12 cells and primary cultured rat dorsal root ganglion (DRG) neurons. Furthermore, Nrf2 DNA binding activity was increased by DMF and MMF in PC12 cells. These findings suggest that DMF, which activates Nrf2 pathway, has a potential protective action against chemotherapy-induced neurotoxicity, particularly neurite impairments.

Original languageEnglish
Pages (from-to)202-211
Number of pages10
JournalJournal of Pharmacological Sciences
Volume137
Issue number2
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

oxaliplatin
Drug Therapy
Fumarates
PC12 Cells
Cultured Cells
Spinal Ganglia
Neuroprotective Agents
Peripheral Nervous System Diseases
Neurites
Paclitaxel
Cisplatin
Action Potentials
Multiple Sclerosis
Cell Death
Up-Regulation
Antioxidants
In Vitro Techniques
Dimethyl Fumarate
Neurons
DNA

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro. / kawashiri, takehiro; Miyagi, Anna; Shimizu, Shiori; Shigematsu, Nao; Kobayashi, Daisuke; Shimazoe, Takao.

In: Journal of Pharmacological Sciences, Vol. 137, No. 2, 01.06.2018, p. 202-211.

Research output: Contribution to journalArticle

@article{70ef7c1d193747b7945933fb39475780,
title = "Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro",
abstract = "Chemotherapy agents such as oxaliplatin, cisplatin, paclitaxel, and bortezomib frequently cause severe peripheral neuropathy and there is currently no effective strategy to prevent this. Dimethyl fumarate (DMF) is a new oral drug for the treatment of multiple sclerosis, and has neuroprotective effects via up-regulation of the nuclear factor-erythroid-2-related factor 2 (Nrf2)-dependent antioxidant response. In this study, we investigated the effect of DMF on chemotherapy agent-induced neurodegenerations in cultured cells. We found that DMF and its metabolite monomethyl fumarate (MMF) attenuated oxaliplatin-, cisplatin-, and bortezomib- (but not paclitaxel-) induced inhibition of neurite outgrowth, but had no effect on cell death as a result of these agents in cultured PC12 cells and primary cultured rat dorsal root ganglion (DRG) neurons. Furthermore, Nrf2 DNA binding activity was increased by DMF and MMF in PC12 cells. These findings suggest that DMF, which activates Nrf2 pathway, has a potential protective action against chemotherapy-induced neurotoxicity, particularly neurite impairments.",
author = "takehiro kawashiri and Anna Miyagi and Shiori Shimizu and Nao Shigematsu and Daisuke Kobayashi and Takao Shimazoe",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.jphs.2018.06.008",
language = "English",
volume = "137",
pages = "202--211",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8613",
publisher = "Japanese Pharmacological Society",
number = "2",

}

TY - JOUR

T1 - Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro

AU - kawashiri, takehiro

AU - Miyagi, Anna

AU - Shimizu, Shiori

AU - Shigematsu, Nao

AU - Kobayashi, Daisuke

AU - Shimazoe, Takao

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Chemotherapy agents such as oxaliplatin, cisplatin, paclitaxel, and bortezomib frequently cause severe peripheral neuropathy and there is currently no effective strategy to prevent this. Dimethyl fumarate (DMF) is a new oral drug for the treatment of multiple sclerosis, and has neuroprotective effects via up-regulation of the nuclear factor-erythroid-2-related factor 2 (Nrf2)-dependent antioxidant response. In this study, we investigated the effect of DMF on chemotherapy agent-induced neurodegenerations in cultured cells. We found that DMF and its metabolite monomethyl fumarate (MMF) attenuated oxaliplatin-, cisplatin-, and bortezomib- (but not paclitaxel-) induced inhibition of neurite outgrowth, but had no effect on cell death as a result of these agents in cultured PC12 cells and primary cultured rat dorsal root ganglion (DRG) neurons. Furthermore, Nrf2 DNA binding activity was increased by DMF and MMF in PC12 cells. These findings suggest that DMF, which activates Nrf2 pathway, has a potential protective action against chemotherapy-induced neurotoxicity, particularly neurite impairments.

AB - Chemotherapy agents such as oxaliplatin, cisplatin, paclitaxel, and bortezomib frequently cause severe peripheral neuropathy and there is currently no effective strategy to prevent this. Dimethyl fumarate (DMF) is a new oral drug for the treatment of multiple sclerosis, and has neuroprotective effects via up-regulation of the nuclear factor-erythroid-2-related factor 2 (Nrf2)-dependent antioxidant response. In this study, we investigated the effect of DMF on chemotherapy agent-induced neurodegenerations in cultured cells. We found that DMF and its metabolite monomethyl fumarate (MMF) attenuated oxaliplatin-, cisplatin-, and bortezomib- (but not paclitaxel-) induced inhibition of neurite outgrowth, but had no effect on cell death as a result of these agents in cultured PC12 cells and primary cultured rat dorsal root ganglion (DRG) neurons. Furthermore, Nrf2 DNA binding activity was increased by DMF and MMF in PC12 cells. These findings suggest that DMF, which activates Nrf2 pathway, has a potential protective action against chemotherapy-induced neurotoxicity, particularly neurite impairments.

UR - http://www.scopus.com/inward/record.url?scp=85049349026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049349026&partnerID=8YFLogxK

U2 - 10.1016/j.jphs.2018.06.008

DO - 10.1016/j.jphs.2018.06.008

M3 - Article

VL - 137

SP - 202

EP - 211

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8613

IS - 2

ER -